Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy

Clinical trial NCT03067831 · UNKNOWN

Trial details

NCT number: NCT03067831
Sponsor: Stem Cells Arabia
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy

Start date: 2015-09-01
Primary completion: 2021-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.